SEC 13F Intelligence

First Light Asset Management, LLC / KROS

First Light Asset Management, LLC’s Keros Therapeutics Inc Position

Does First Light Asset Management, LLC own Keros Therapeutics Inc (KROS)? Not currently — the last reported position was 421.4K shares worth $13M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q3 2023
Shares
421.4K
% of Portfolio
+1.28%
Quarters Held
9
position exited

Position History KROS

Reported value by quarter
Q3 ’21: $7MQ3 ’21Q4 ’21: $32MQ1 ’22: $36MQ1 ’22Q2 ’22: $17MQ3 ’22: $23MQ3 ’22Q4 ’22: $28MQ1 ’23: $25MQ1 ’23Q2 ’23: $17MQ3 ’23: $13MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023421.4K$13M+1.28%
Q2 2023416.8K$17M+1.31%
Q1 2023594.0K$25M+2.28%
Q4 2022592.4K$28M+2.64%
Q3 2022598.2K$23M+2.28%
Q2 2022598.3K$17M+1.92%
Q1 2022658.1K$36M+3.16%
Q4 2021552.1K$32M+2.31%
Q3 2021173.2K$7M+0.45%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First Light Asset Management, LLC’s full portfolio or all institutional holders of KROS.